← Leaderboards
Cory Funk
University Of Washington
$897,683
Attributed
$2,693,048
Total exposure
1
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3.8M · FY2019–23$5M$3.8M$2.5M$1.3M$0
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$11,927,643 · 2
By mechanism
U01$9,234,595 · 1
R01$2,693,048 · 1
Top collaborators
- Martin C Darvas5 shared
- Christine Michelle Johnston5 shared
- Nilufer Ertekin-Taner4 shared
- Todd E. Golde4 shared
Most similar at University Of Washington
Same institution · by research overlap
- Albert R La Spada$44,944,106
- Deirdre R. Meldrum$57,678,697
- Jeffrey A Ranish$6,956,314
- Alexander P Reiner$25,408,009
- Ake Lernmark$26,724,028
Others in their field
Other Emerging Leaders on “Alzheimer&Apos”
- Lance Allen Johnson · University Of Kentucky$7,508,882
- Hyacinth Idu Hyacinth · University Of Cincinnati$6,781,590
- Yi Su · Weill Medical Coll Of Cornell Univ$6,486,733
- Julia Tcw · Icahn School Of Medicine At Mount Sinai$6,079,215
- Jessica Brooke Langbaum · Banner Health$6,050,741
- Timothy Yikai Huang · Sanford Burnham Prebys Medical Discovery Institute$5,936,362
Research focus
Alzheimer&AposGenetic TranscriptionNatural ImmunityComparativeS DiseaseTranscriptomicsInsightPathway AnalysisBrainSliceMedicinePathologicMouse ModelPathologyS Disease RiskElderlyAmyloidBrain RegionAffectGenotypeGenesIn VivoTau ProteinsPlay
Grant awards (9)
Modulation of Alzheimers disease by Herpes simplex virus infectionÂ$430,231
R01 · FY2023 · AG
A Systems Approach to Targeting Innate Immunity in AD$2,421,378
U01 · FY2022 · AG
Modulation of Alzheimers disease by Herpes simplex virus infectionÂ$513,438
R01 · FY2022 · AG
A Systems Approach to Targeting Innate Immunity in AD$391,250
U01 · FY2022 · AG
A Systems Approach to Targeting Innate Immunity in AD$3,188,314
U01 · FY2021 · AG
Modulation of Alzheimers disease by Herpes simplex virus infectionÂ$554,804
R01 · FY2021 · AG
A Systems Approach to Targeting Innate Immunity in AD$3,233,653
U01 · FY2020 · AG
Modulation of Alzheimers disease by Herpes simplex virus infectionÂ$575,841
R01 · FY2020 · AG
Modulation of Alzheimers disease by Herpes simplex virus infectionÂ$618,734
R01 · FY2019 · AG